Biotech

Page 4 of 19

Can an A.I. algorithm spot the next Facebook or Uber? The founder of this European VC firm thinks so
Newsletters

Can an A.I. algorithm spot the next Facebook or Uber? The founder of this European VC firm thinks so

By
May 24, 2023
Pipette adding sample to petri dish with DNA profiles in background
Newsletters

A.I.-fueled biotech startups are having a moment—and one just raised $300 million in a Series A

By
May 23, 2023
How Horizon Therapeutics sold to Amgen for $27.8 billion without ever licensing a drug of its own
Health

How Horizon Therapeutics sold to Amgen for $27.8 billion without ever licensing a drug of its own

By Arthur Allen and KFF Health News
April 13, 2023
The Silicon Valley Bank meltdown could be a disaster for downtrodden biotech startups
Tech

The Silicon Valley Bank meltdown could be a disaster for downtrodden biotech startups

By Angelica Peebles, Ilena Peng and Bloomberg
March 10, 2023
The 11 most promising health tech startups, according to Silicon Valley VCs
Tech

The 11 most promising health tech startups, according to Silicon Valley VCs

By
October 24, 2022
Health Tech startups are booming. These 11 VC investors are behind some of the hottest deals
Tech

Health Tech startups are booming. These 11 VC investors are behind some of the hottest deals

By
September 23, 2022
Joe Biden in front of an American flag.
Finance

Biden’s new executive order triggers new front in U.S.-China economic competition

By
September 12, 2022
President Joe Biden signs executive order addressing semiconductors shortage in February.

Biden to spur biomanufacturing, reduce reliance on China with executive order  

By Riley Griffin and Bloomberg
September 10, 2022
Mother holds child's hand
Health

Parents are becoming drug developers to find a cure for their children’s rare diseases

By Jared Whitlock and Kaiser Health News
July 21, 2022
ESG investors shouldn’t ignore biotech’s potential to deliver change
Commentary

ESG investors shouldn’t ignore biotech’s potential to deliver change

By
May 2, 2022
Albert Bourla, chairman and chief executive officer of Pfizer Inc., speaks during South By Southwest.
Health

The most innovative and inventive drug companies of 2022 set the foundation for success before the pandemic

By Sy Mukherjee and IDEA Pharma
April 20, 2022
female scientists in a lab
Finance

Investors are moving away from biotech stocks as COVID wanes

By Angelica Peebles and Bloomberg
February 14, 2022
Gloved hand holding pills in front of Sanofi corporate logo
Health

Sanofi agrees to partnership with A.I.-based drug discovery company Exscientia worth up to $5.2 billion

By
January 7, 2022
A health worker speaks with a patient in the reception area of a Testaro Covid-19 testing site in the Goodwood district of Cape Town, South Africa,
Health

Omicron vaccine to begin clinical trial in South Africa

By
December 6, 2021
Future 50 2021-Moderna
Magazine

Moderna’s COVID vaccine success made the stock a big pandemic winner. Will the run continue?

By
December 2, 2021

Most Popular